Cost Effectiveness of DOTS and Non-DOTS Strategies for Smear-positive Pulmonary Tuberculosis in Beijing

被引:0
|
作者
XU QUN *
** Information Center for Public Health
机构
关键词
<Keywor;
D O I
暂无
中图分类号
R521 [肺结核];
学科分类号
1002 ; 100201 ;
摘要
The cost effectiveness of DOTS (Directly Observed Treatment, short course) and non DOTS strategies for smear positive pulmonary tuberculosis in Beijing was evaluated. Cost calculation was based on the expenses of drugs, chest X ray films, sputum smears and cultures for the patients. Effectiveness of the intervention was assessed in two aspects: direct benefits to the patients treated and indirect benefits to the others through reduced transmission of tuberculosis; disability adjusted life of year (DALY) was used as an index. The results showed that one DALY could be saved with 45.7 Yuan by DOTS and 471.4 Yuan by non DOTS. DOTS is a good control strategy for smear positive tuberculosis.
引用
收藏
页码:307 / 313
页数:7
相关论文
共 50 条
  • [1] Cost effectiveness of DOTS and non-DOTS strategies for smear-positive pulmonary tuberculosis in Beijing
    Xu, Q
    Jin, SG
    Zhang, LX
    [J]. BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2000, 13 (04) : 307 - 313
  • [2] Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil
    Steffen, Ricardo
    Menzies, Dick
    Oxlade, Olivia
    Pinto, Marcia
    de Castro, Analia Zuleika
    Monteiro, Paula
    Trajman, Anete
    [J]. PLOS ONE, 2010, 5 (11):
  • [3] Trend in the incidence of smear-positive tuberculosis in a district in South India after DOTS implementation
    Subramani, R.
    Gomathy, S.
    Lakshmi, M.
    Swaminathan, S.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (08) : 1022 - 1026
  • [4] Registration and treatment of patients with smear-positive pulmonary tuberculosis
    Nyirenda, T
    Harries, AD
    Banerjee, A
    Salaniponi, FM
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (11) : 944 - 945
  • [5] Sputum smears for diagnosis of smear-positive pulmonary tuberculosis
    Harries, AD
    Kamenya, A
    Subramanyam, VR
    Salaniponi, FM
    Nyangulu, DS
    [J]. LANCET, 1996, 347 (9004): : 834 - 835
  • [6] Effectiveness of a case management model in newly treated smear-positive pulmonary tuberculosis patients
    Li, YanLing
    Wang, Ying
    Wang, GaiJing
    Wang, YiLin
    Tian, YanQing
    Zhu, SiWei
    Chen, Jiao
    Diao, LiLi
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (11): : 1670 - 1676
  • [7] Trends in sputum smear conversion among smear-positive pulmonary tuberculosis patients
    Acquah, S. E. K.
    Quaye, L.
    Walana, W.
    Vicar, E. K.
    Osei, Y. N.
    Amedor, C.
    Yahaya, A. I.
    Ziem, J. B.
    [J]. JOURNAL OF MEDICAL AND BIOMEDICAL SCIENCE, 2015, 4 (01): : 24 - 33
  • [8] Tuberculosis recurrence in smear-positive patients cured under DOTS in southern Ethiopia: retrospective cohort study
    Daniel G Datiko
    Bernt Lindtjørn
    [J]. BMC Public Health, 9
  • [9] Tuberculosis recurrence in smear-positive patients cured under DOTS in southern Ethiopia: retrospective cohort study
    Datiko, Daniel G.
    Lindtjorn, Bernt
    [J]. BMC PUBLIC HEALTH, 2009, 9
  • [10] Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis
    Wang, Jann-Yuan
    Lee, Li-Na
    Yu, Chong-Jen
    Chien, Yin-Ju
    Yang, Pan-Chyr
    [J]. RESPIROLOGY, 2009, 14 (07) : 1012 - 1019